4/A: Revolution Medicines Director Sandra Horning Amends Filing to Correct Stock Option and RSU Award Amounts

Sandra Horning, a director at Revolution Medicines, filed an amended Form 4 to correct previously reported amounts for restricted stock units and stock options granted on June 20, 2024.

Summary

• Sandra Horning, a director at Revolution Medicines, filed an amendment to a previous Form 4 filing.
• The amendment corrects the amounts reported for restricted stock units (RSUs) and stock options granted to Horning on June 20, 2024.
• The corrected filing shows that Horning was granted 2,945 shares of common stock and 10,248 stock options at an exercise price of $37.54 on June 20, 2024.
• Following the transaction, Horning beneficially owns 93,432 shares of common stock, including 11,695 RSUs, and 10,248 stock options.
• The stock options vest on the earlier of the first anniversary of June 20, 2024, or immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to continued service.

Sentiment

Score: 7

Explanation: The document is a routine correction of a previous filing, indicating standard corporate governance practices. It doesn't contain any alarming or negative information, but it's not particularly positive either.

Future Outlook

The stock options vest on the earlier of the first anniversary of June 20, 2024, or immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to continued service.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, such as directors and officers. Amendments are sometimes necessary to correct errors in the original filings.

Stakeholder Impact

• The correction of the filing ensures transparency for shareholders regarding insider ownership.

Key Dates